Sichenzia Ross Friedman Ference LLP Represents Trovagene, Inc. on $40.3M Public Offering of Common Stock
Press Release – New York, NY – July 22, 2015—New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Trovagene, Inc. (NASDAQ: TROV), a company focused on the research and development of precision cancer monitoring technology, on an underwritten public offering consisting of 4,600,000 shares of the Company’s common stock priced to the public at $8.75 per share. Trovagene raised approximately $40.3 million in gross proceeds.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey Fessler and Tara Guarneri-Ferrara. Piper Jaffray & Co. and Leerink Partners LLC acted as the underwriters for the offering. Additionally, Janney Montgomery Scott LLC, Cantor Fitzgerald & Co. and Maxim Group LLC acted as co-managers for the offering.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Founding Partner Gregory Sichenzia Featured in Business Insider Discussing the Legal Aftermath for Tesla - September 19, 2018
- Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for AusCann Group Holdings Ltd on OTCQX Listing - September 15, 2018
- Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Zelda Therapeutics Ltd on OTCQX Listing - September 15, 2018